Background {#Sec1}
==========

Yellow fever virus (YFV) causes yellow fever (YF), an acute disease affecting humans and non-human primates (NHP) in several South American and African countries \[[@CR1], [@CR2]\]. In humans, YF ranges from asymptomatic infection to non-specific symptomatic illness and fatal hemorrhagic fever \[[@CR1], [@CR2]\]. Despite the existence of a safe vaccine, massive YF outbreaks occurred recently in Angola, Democratic Republic of Congo \[[@CR3]\], and Brazil \[[@CR4]--[@CR6]\]. Humans are considered incidental hosts for YFV. The virus is maintained by different cycles in tropical and subtropical regions of sub-Saharan Africa and South America via transmission among different mosquitoes and NHP \[[@CR2], [@CR7]--[@CR9]\]. Most of the experimental studies with YFV were performed with Old World NHP, but little is known about YF and the pathogenesis in Neotropical NHP. Neotropical NHP are considered highly susceptible to YFV infection \[[@CR10]\], which may be related to the recent introduction of the virus into the Americas \[[@CR7]\]. Given the ongoing YF outbreaks in Brazil (2016--2019), we present the main aspects of sylvatic YF, including historical and recent outbreaks in the country.

Main text {#Sec2}
=========

The virus and transmission cycle {#Sec3}
--------------------------------

YFV is the prototype member of the genus *Flavivirus* (family Flaviviridae), with a single-strand positive-sense RNA genome of approximately 11 kb \[[@CR11]\]. The genome has a 5′ end cap structure, and it is translated into a polyprotein precursor. The polyprotein is then cleaved by viral and cellular proteases into three structural proteins (capsid, envelope, and membrane proteins) and seven non-structural proteins (named NS1, NS2A, NS2B, NS3, NS4A, NS4B, and NS5) \[[@CR11]\].

Until now, one YFV serotype and seven genotypes have been described in Africa and South America. In Africa, five genotypes are described, named West Africa I, West Africa II, East Africa, East/Central Africa, and Angola \[[@CR12], [@CR13]\]. In Africa, there are three transmission cycles: (*i*) the sylvatic cycle is reported in the rainforest, involving NHP and sylvatic *Aedes africanus*, (*ii*) the intermediate cycle in the forest-savanna ecotone has peridomestic anthropophilic *Aedes spp.* (such as *A. furcifer*, *A. taylori*, *A. luteocephalus*, and *A. simpsoni*) as vectors, and (*iii*) the urban cycle has *Aedes aegypti* and *Aedes bromeliae* as vectors \[[@CR12], [@CR13]\]. In South America, YFV is endemic in the Amazon Basin (Brazil, Peru, Bolivia, Colombia, Ecuador, Venezuela, French Guiana, Suriname, and Guyana) \[[@CR1], [@CR14]\] and the sylvatic cycle involves various species of NHP and mosquitoes primarily belonging to the genera *Haemagogus and Sabethes* \[[@CR15]\]. YFV South American I and II genotypes are derived from the West African genotype \[[@CR16], [@CR17]\]. South American I is the predominant YFV genotype in Brazil, possessing five distinct lineages 1A-1E \[[@CR17], [@CR18]\]. Until the middle of the 1990s, the old lineages (1A, 1B, and 1C) co-circulated in South America but were then replaced by the modern ones, 1D and 1E \[[@CR8], [@CR17]--[@CR19]\]. Lineage 1E is responsible for the recent YF outbreaks in Brazil (2016 to 2019), and it was probably originated from YF endemic areas in North Brazil \[[@CR20], [@CR21]\]. Genomic analyses of YFV causing the recent outbreaks revealed unique mutations leading to nine amino acid substitutions in the deduced polyprotein (eight substitutions in highly conserved positions of non-structural proteins 3 and 5, which form the replication complex of YFV). Those amino acid substitutions have not been previously described for YFV, and the impacts of those changes in viral fitness should be investigated \[[@CR19], [@CR22]\].

Recent clinical findings in yellow fever patients {#Sec4}
-------------------------------------------------

YF has been described as a viscerotropic disease in humans, with viral replication playing a crucial role in pathogenesis \[[@CR23]\]. The viscerotropic YF has been divided into three periods: (i) infection, characterized by viremia and occurrence of flu-like symptoms; (ii) remission, when seroconversion is observed while fever and symptoms bounce back or disappear; and (iii) intoxication, which affects 15--25% of symptomatic patients. During the intoxication period, symptoms reappear, including hemorrhagic fever, multi-organ dysfunction, jaundice, oliguria, anuria, renal failure, and cardiovascular instability \[[@CR1], [@CR23]\]. Among the severe cases, global mortality varies from 5 to 10%, but 40% of lethality has already been described in Brazil \[[@CR2]\].

During the recent epidemics in Brazil, the most common signs and symptoms observed in humans were fever, headache, vomiting, jaundice, chills, nausea, abdominal pain, myalgia, arthralgia, rash, diarrhea, bleeding or hemorrhagic signs \[[@CR24]--[@CR27]\]. Recently, in severe YF cases, a critical metabolic acidosis leading to the need for hemodialysis \[[@CR25]\], increased levels of serum lipase \[[@CR25], [@CR28]\] and a high prevalence of pancreatitis were observed \[[@CR25]\]. These studies highlighted the importance of pancreatitis in the evolution of YF and the need for further studies addressing this issue \[[@CR25], [@CR28]\].

Other studies have demonstrated different outcomes and patterns regarding YF infection. Although YF is mainly viscerotropic in humans, Marinho and colleagues (2019) described a case of a 3-year-old girl with severe manifestations in the central nervous system. The patient had mildly elevated amino transaminases but no classical YF signs or symptoms. After six days of hospitalization, the child died, and postmortem analysis showed wild-type YFV RNA in the cerebrospinal fluid \[[@CR29]\]. The persistence of the wild-type YFV genome has been demonstrated in serum \[[@CR28]\] and in urine \[[@CR28], [@CR30]\], until 28 and 47 days after the onset of symptoms, respectively. These findings indicate that YFV might persist in the host for more extended periods than previously thought. During the follow-up of two YF patients, increased levels of serum alanine transaminase (ALT) and serum aspartate transaminase (AST) (ALT \> 1000 IU/L and AST \> 301 IU/L) were observed two months after the onset of YF. The serum transaminases persisted elevated for up to six months \[[@CR31]\], indicating the need for further studies on the convalescence phase of YF.

Studies have also been conducted to investigate the predictors of severity and death in different groups of YF patients. Age and elevated levels of AST, ALT, and creatinine have been independently associated with mortality in YF patients \[[@CR26]\], while higher values of serum lipase and lower values of factor V were related to severe cases \[[@CR28]\]. Kallas and colleagues (2019) analyzed data from 76 YF patients and observed that age, neutrophil count, AST, and viral load were independently related with death \[[@CR27]\]. Clinical and laboratory indicators could support the management of patients and the establishment of prognosis. However, one should keep in mind that YF evolves rapidly, and clinical characteristics may vary according to different factors related to the host and the phase of infection.

Yellow fever surveillance and control {#Sec5}
-------------------------------------

Since all South American NHP are highly susceptible to YFV infection, and epizootics often precede human cases, NHP can be used as sentinels during surveillance programs \[[@CR8]\]. In 1999, the Brazilian Ministry of Health (MOH) launched the Epizootics Surveillance Program aiming at the investigation of NHP epizootics and entomological surveillance \[[@CR32]\]*.* After the detection of epizootics causing the death of NHP in a region, a survey of the vaccination history of residents near the site, an active search for suspected human cases, and biological sample collection for laboratory investigation are conducted. For YF diagnosis in NHP, organ fragments, especially the liver, but also spleen, kidney, heart, lungs, and brain are collected and forwarded to one of the Reference Laboratories linked to the MOH. These samples are used for investigation by immunohistochemistry, histopathology, viral isolation, or by molecular tests \[[@CR33]\]. Immunohistochemistry and histopathology analyses allow the detection of YFV antigens and the identification of histological alterations observed in YF, respectively. Although there is scarce information regarding the infection of monkeys by other flaviviruses, some studies have detected Zika virus RNA in NHP, during the latest YFV outbreaks in Brazil \[[@CR34], [@CR35]\]. Faced with this, molecular techniques such as RT-qPCR have become the most reliable and specific tool to diagnose and confirm YFV infection.

YF laboratory diagnosis is performed through virologic or serological methods using human samples, by the Reference Laboratories linked to the MOH. For molecular detection of YFV RNA by RT-qPCR, sera collected from the first up to the 10th day after the onset of symptoms is recommended, and the positive result confirms YFV infection. Serological tests, especially MAC-ELISA to detect IgM antibodies, are recommended to be used after seroconversion, from the sixth day after the onset of symptoms. Due to the high probability of cross-reactivity with other flaviviruses, which are widespread throughout the same regions of YFV occurrence, the detection of IgM anti-YFV is only presumptive of recent infection \[[@CR36], [@CR37]\].

Since YF is a disease of immediate compulsory notification, the suspected human cases and NHP epizootics should be reported within 24 h of initial suspicion \[[@CR32], [@CR37]\]*.* Surveillance and precise diagnosis of YF are essential since they may support control measures such as vaccination \[[@CR38]\]*.* YF vaccination recommendation was expanded in Brazil and now includes all states from North, South, Southeast, and Midwest regions and parts of the Northeast region (Maranhão, Bahia, and some municipalities in Piauí, Alagoas, and Sergipe) \[[@CR6]\]. A single dose of the YF vaccine is recommended for lifelong protection \[[@CR39], [@CR40]\], however, this is still an issue of debate. Studies have demonstrated a significant decreasing or even the complete absence of neutralizing antibody titers, effector memory CD4^+^ and CD8^+^ T-cells and classical memory B-cells ten years after primary YF vaccination \[[@CR41]--[@CR43]\].

Regardless of the relative safety of the vaccine strains, some adverse events following YF vaccination have been described \[[@CR38], [@CR44]\]. In Brazil, from 2007 to 2012, the occurrence of adverse events was estimated as 0.42 events per 100,000 inhabitants \[[@CR45]\]. In recent epidemics in Minas Gerais state from 2017 to 2018, more than 7.1 million YFV-17DD vaccine doses were given, and only one case of vaccination-associated disease was confirmed to date \[[@CR46]\].

Much is debated on the vaccination of NHP against YF. The immunization of NHP could reduce virus circulation significantly in risk areas and, consequently, the chances of infection in humans. Besides, this strategy could help the preservation and protection of monkey populations. On the other hand, some points need to be taken into consideration. There are not enough studies regarding the effect of the vaccine in Neotropical NHP and, given the differences in susceptibility to YFV, the vaccine dose would have to be adjusted for each species. There are also logistics and cost aspects related to the capture of the animals to be considered \[[@CR47]\]. Finally, epizootics surveillance programs could fail in early detection of YFV circulation, due to the loss of naïve sentinel NHP.

Sylvatic yellow fever in Brazil {#Sec6}
-------------------------------

During the 18th and 19th centuries, YFV caused devastating urban outbreaks in the Americas, and it was considered one of the most dangerous diseases of that period \[[@CR12]\]. At the beginning of the twentieth century, campaigns focused on eradicating the *vector A. aegypti* started in several places in South America \[[@CR48]\], leading to the eradication of the YF urban cycle in many countries, including Brazil. The last urban YF epidemic in Brazil was reported in 1929 in Rio de Janeiro state, and the ultimate YF urban case was documented in 1942, in Acre state \[[@CR49]\].

The sylvatic cycle of YF in Brazil was observed in 1889, by Adolpho Lutz, and in 1899, by Emilio Ribas, when YF human cases occurred in *A. aegypti*-free areas, in São Paulo state \[[@CR50]\]. However, only in 1932, the occurrence of the sylvatic cycle of YF was confirmed in Espírito Santo state \[[@CR51]\]. In the following years (1933, 1934, 1935, 1936, 1938, 1939, 1944, 1950, 1957, and 1964), several sylvatic YF outbreaks were reported all over Brazil, in North (Amazonas and Pará states), Northeast (Bahia state), Midwest (Mato Grosso and Goiás states), Southeast (Minas Gerais, São Paulo, Rio de Janeiro, and Espírito Santo states), and South (Paraná, Santa Catarina, and Rio Grande do Sul states) regions. From 1932 to 1967, a total of 1672 human cases linked to sylvatic YF were confirmed \[[@CR50]\]. Later, YF outbreaks were mostly reported in the Amazon Basin (North and Midwest regions), and sporadic cases occurred in Minas Gerais state \[[@CR2], [@CR52]\]. After 1999, the epidemiological scenario of sylvatic YF changed, and the majority of human cases occurred outside the Amazon Basin, in the Midwest, Southeast, and South regions of Brazil \[[@CR2], [@CR52]\]. From 1980 to mid-2015, 792 sylvatic YF human cases and 421 deaths took place in the country (data received from SINAN, June 2019) .

In 2016, a sylvatic YF outbreak started in Minas Gerais state, and then it spread to São Paulo, Espírito Santo, Rio de Janeiro, and Bahia states in 2017 \[[@CR4], [@CR5]\]. The YFV lineage causing this outbreak was estimated to exist for at least two years before the outbreak and likely reached the Southeast region by passing through the Midwest region of Brazil \[[@CR53], [@CR54]\]. YFV-positive NHP were detected in Minas Gerais state throughout 2017 until mid-2018 \[[@CR55], [@CR56]\]. These findings raised the possibility of viral persistence in the Southeast region, which was later confirmed \[[@CR54], [@CR57]\]. YFV cases occurred until 2018 \[[@CR53], [@CR54]\] in Minas Gerais, Rio de Janeiro, Espírito Santo, and São Paulo states \[[@CR5]\]. In 2019, YF outbreaks were reported in São Paulo, and the virus spread to Santa Catarina and Paraná states \[[@CR6]\].

The 2016--2019 YF outbreaks in Brazil have been considered the most significant ones of the last 70 years. From December 2016 until June 2019, more than 15,000 NHP epizootics were reported in Brazil \[[@CR4]--[@CR6]\], in sylvatic, rural, and urban areas, as reported by local media \[[@CR58]\]. Laboratory tests or epidemiological criteria confirmed at least 1567 epizootic events caused by YF, in 455 municipalities, in Southeast (90.9%), South, Northeast, Midwest, and North regions (Fig. [1](#Fig1){ref-type="fig"}) \[[@CR55], [@CR60]--[@CR73]\]. Fig. 1Sylvatic yellow fever (YF) human cases and epizootics occurrence in Brazil, from 2016 to 2019. The map presents the Amazon (in light green), Caatinga (in light orange), Cerrado (in light yellow), Atlantic Forest (in dark green), Pampa (in dark yellow), and Pantanal (in light brown) biomes in Brazil. Municipalities are colored according to YF cases in non-human primate (NHP) (in blue), in humans (in grey), and both in humans and NHP (in red). Brazilian states abbreviations are as follows: North: AC (Acre), AP (Amapá), AM (Amazonas), PA (Pará), RO (Rondônia), RR (Roraima), and TO (Tocantins); Northeast: AL (Alagoas), BA (Bahia), CE (Ceará), MA (Maranhão), PB (Paraíba), PE (Pernambuco), PI (Piauí), RN (Rio Grande do Norte), and SE (Sergipe); Midwest: MT (Mato Grosso), MS (Mato Grosso do Sul), GO (Goiás), and DF (Federal District/Brasília); Southeast: MG (Minas Gerais), SP (São Paulo), RJ (Rio de Janeiro), and ES (Espírito Santo); South: RS (Rio Grande do Sul), PR (Paraná), and SC (Santa Catarina). The map was created using QGIS v.2.18.16 \[[@CR59]\]. The numbers of YF cases were obtained from Sistema de Informação de Agravos de Notificação (SINAN) and official bulletins from the Brazilian Ministry of Health Brazil and State Health Departments \[[@CR60]--[@CR73]\]. YF: yellow fever. H: humans. NHP: non-human primates

In Brazil, most of human YF cases are described in males aged 14 to 35, who are more exposed to YFV by occupational or ecotourism activities in rural and sylvatic endemic regions. However, since the end of the 1990s, the numbers of YF cases among women and younger people have been increasing \[[@CR2]\]. At least 2251 human cases and 772 deaths were confirmed in Brazil, from December 2016 to June 2019 \[[@CR4]--[@CR6]\]. These numbers demonstrate an increase of 2.82 times the total of YF human cases and 1.57 times the sum of YF human deaths, compared to the previous 36 years (from 1980 to 2015) (Fig. [2](#Fig2){ref-type="fig"}). Human cases were confirmed in 388 municipalities in the Southeast (96%), South, Midwest, and North regions \[[@CR60]--[@CR73]\] (Fig. [1](#Fig1){ref-type="fig"}). These data illustrate the magnitude of the recent YF epidemics in Brazil, reaching extensive YF-free areas. Fig. 2Historical series of sylvatic yellow fever human cases in Brazil, from 1980 to June 2019. The numbers of cases (grey line) and the lethality rate (red dotted line) are showed by year (1980--2015) or by epidemiological periods (EP) (July to June of 2016/2017, 2017/2018, and 2018/2019). The numbers of YF cases were obtained from Sistema de Informação de Agravos de Notificação (SINAN) and official bulletins from the Brazilian Ministry of Health Brazil and State Health Departments \[[@CR60]--[@CR73]\]

Yellow fever virus vectors in Brazil {#Sec7}
------------------------------------

Unlike NHP and humans, which succumb to the disease or heal by developing long-term immunity, mosquitoes are considered reservoirs of YFV since they remain infected and can transmit the virus throughout life \[[@CR2], [@CR74]\]. In Brazil, species within the genera *Haemagogus* (*H. janthinomys*, *H. albomaculatus*, *H. leucocelaenus*, *H. capricornii*, and *H. spegazzinii*) and *Sabethes* (*S. chloropterus*, *S. soperi*, *S. cyaneus*, *S. glaucodaemon*, and *S. albiprivus*) are the primary sylvatic YFV vectors \[[@CR2], [@CR33], [@CR75]\]. YFV-naturally infected specimens of *Aedes scapularis*, *Aedes taeniorhynchus*, *Aedes serratus*, and *Psorophora ferox* have been reported in Brazil, however, these mosquitoes are not considered primary YFV vectors \[[@CR75]--[@CR79]\].

*H. janthinomys* and *H. leucocelaenus* have a wide distribution in the South American continent and are considered the main YFV vectors in the Americas and South/Southeast Brazil, respectively \[[@CR80], [@CR81]\]*.* Females of *Haemagogus* spp. are hematophagous and exhibit primatophilic daily activity. They have vertically stratified spatial distribution and are mostly found in the forest canopy (acrodendrophilic behavior) \[[@CR82], [@CR83]\]. Female mosquitoes prefer oviposition in phytotelmata, such as tree hollows, bamboo internodes, bromeliads and leaf axis \[[@CR84]\]. Later on, the immature stages (eggs, larvae, and pupa) develop in those phytotelmata. *Haemagogus* females seek and bite their hosts mostly in the afternoon or during the warmest hours of the day \[[@CR2], [@CR76], [@CR80], [@CR85]\].

*Sabethes* spp. share some ecological characteristics with *Haemagogus* spp., such as the daily activity, primatophilia, acrodendrophilia, and preferential oviposition in tree hollows. While some species are widespread in Central and South America (*Sabethes chloropterus* and *Sabethes cyaneus*), others seem to be restricted to South America (*Sabethes glaucodaemon*, *Sabethes soperi*, and *Sabethes albiprivus*) \[[@CR86]\]*.* Within the genera, *S. chloropterus* is limited to forest areas and considered the primary YFV sylvatic vector. Their eggs can persist through the dry season, which is probably a key factor in YFV maintenance through unfavorable dry periods \[[@CR86]\].

Sylvatic YFV vectors are abundant in the treetops, with daytime activity peaking in the hottest hours of the day, corresponding to the resting period of the NHP in the canopy \[[@CR87]\], favoring the hematophagy in NHP. *H. leucocelaenus* and *H. janthinomys* are primatophilic species, but occasionally they can be found at ground level in areas surrounding \[[@CR88]\] or distant from the forests, including indoors \[[@CR89]\], since they can can travel for long distances, as 5.7 km and 11.5 km, respectively \[[@CR90]\]. *H. leucocelaenus* can adapt to human-modified environments, as periurban \[[@CR83], [@CR86]\] and urban areas \[[@CR91]\]. YFV-infected specimens of *H. janthynomis* have already been sampled in regions near or contiguous to urban neighborhoods \[[@CR75], [@CR92]\]. In that way, these mosquito species could play a significant role in viral maintenance in forest settings and in viral dissemination towards peridomestic and urban environments.

Given the ecological plasticity and the ubiquitous environmental distribution of *A. albopictus* (in urban, rural, and forest settings in tropical countries, including Brazil), this mosquito could be a bridge vector between sylvatic and urban environments \[[@CR89], [@CR93]\]. Experimental studies have demonstrated that *A. albopictus* can transmit YFV \[[@CR77], [@CR94]--[@CR96]\], and it was found naturally infected with the virus, in a rural setting of Minas Gerais state, in 2018 \[[@CR97]\]. *Aedes aegypti* is widespread in all the tropical and subtropical regions. This mosquito has anthropophilic and endophilic habits and is the urban vector of YFV \[[@CR81]\]. Despite the sensitivity to YFV infection and the high infestation indices of *A. aegypti* and *A. albopictus* in urban and periurban areas in Brazil \[[@CR75], [@CR77], [@CR98], [@CR99]\], there is no evidence of YFV transmission by *A. aegypti*, since the eradication of urban YF cycle in the country \[[@CR48], [@CR75]\].

Non-human primates in Brazil {#Sec8}
----------------------------

Neotropical NHP are divided into five families (Pitheciidae, Aotidae, Atelidae, Cebidae, and Callitrichidae) \[[@CR100], [@CR101]\]. The most considerable diversity of NHP is observed in Brazil, with a total of 130 species mostly distributed in the Amazon, followed by Atlantic Forest, Caatinga, Cerrado, Pantanal, and Pampa biomes (<https://www.taxeus.com.br/lista/3035>).

The family Pitheciidae comprises NHP without prehensile tails which use quadrupedal locomotion, and most of the species are herbivorous. The species within the genera *Pithecia*, *Cacajao,* and *Chiropotes* are distributed in the Amazon region. However, *Callicebus,* the species-richest genus of Neotropical NHP, has a wide occurrence in the Brazilian territory in areas covered by the Amazon, Atlantic Forest, Caatinga, and Pantanal biomes \[[@CR100], [@CR102]\]. *Callicebus* specimens are much smaller than the other members of the family (0.8--1.5 kg) and differ in social organization, living in small family groups with a single monogamous adult pair. They mainly eat fruits, but also leaves, flowers, insects, bird eggs, and small vertebrates \[[@CR100], [@CR102]\].

The family Aotidae has one genus, *Aotus,* popularly called owl monkeys. Six out of eight *Aotus* species are distributed in the Brazilian Amazon. They are small (0.8 kg to 1.0 kg) and have nocturnal habits \[[@CR102]\]. The owl monkeys live in small groups of 4--6 individuals and feed mainly on leaves, fruits, and invertebrates \[[@CR100]\].

The family Atelidae comprises the largest Neotropical NHP (5 to 15 kg). They have a prehensile tail, are excellent brachiators, and feed mostly on flowers and fruits. The spider monkeys (*Ateles*) and woolly monkeys (*Lagothrix*) are distributed in the Amazon, while the muriquis (*Brachyteles)* are observed in the Atlantic Forest. The howler monkeys (*Alouatta*), recognized by their loud and characteristic vocalization, have slow locomotion and live in small tight groups. Ten species of *Alouatta* are widespread in the Amazon Basin, Atlantic Forest, Cerrado, Caatinga, Pantanal, and Pampa biomes \[[@CR101], [@CR102]\].

The family Cebidae comprises medium-sized animals, which live in large social groups. These NHP are mostly are frugivorous and insectivorous. *Sapajus*, *Cebus*, and *Saimiri* are found in the Amazon, although *Sapajus* specimens have a broad distribution in the Atlantic Forest, Cerrado, Pantanal, and Caatinga biomes \[[@CR101], [@CR102]\].

The family Callitrichidae comprises small animals (120 g to 600 g) that feed on fruits, insects, and plant exudates. The genera *Callimico, Callibella, Cebuella,* and *Saguinus* are distributed in the Amazon, while *Leontopithecus* is present in the Amazon, Pantanal, and Cerrado biomes. The *Callithrix* genus, usually called marmoset, is distributed in the Atlantic Forest, Cerrado, and Caatinga biomes \[[@CR101], [@CR102]\].

As seen above, a great variety of arboreal NHP is found in different geographical areas where the presence of sylvatic vectors is registered. The urbanization and the expansion of agriculture practices have led to extreme habitat degradation, causing the fragmentation NHP populations in Brazil \[[@CR103]\]. Although NHP mostly exist in sylvatic environments, some Neotropical NHP adapt and survive in extremely degraded habitats \[[@CR104], [@CR105]\]*.* Neotropical NHP are potential hosts for YFV due to their ecological and behavioral patterns and their susceptibility to the infection. A variety of factors could alter or lower the exposure rates of NHP to hematophagous insects. For example, the small body and group sizes of some monkeys lead to lower rates of malaria in Amazonian NHP \[[@CR106]\]. Some NHP species exhibiting less mobility, with territorial and quite habits in the tree canopy, as *Alouatta* spp., have higher chances of being bitten and infected \[[@CR103], [@CR107]\]. Social and diet behavior patterns could be modified in disturbed habitats, as already shown for the red howler monkey \[[@CR108]\]. Those behavior changes could, in turn, alter the attractiveness in favor of hematophagous mosquitoes and, consequently, the transmission of viruses.

Yellow fever in non-human primates {#Sec9}
----------------------------------

Old World NHP are sensitive to YFV and develop enough viremia to reinfect mosquitoes but rarely they show clinical signs or die. In Africa, the primary YFV amplifier hosts are *Cercopithecus* spp. (with viremia lasting for three to four days) \[[@CR86]\] and *Colobus* spp. (with viremia detected up to nine days) \[[@CR109]\]. Serological studies indicate that *Cercocebus* spp. (mangabeys) and *Papio* spp. (baboons) \[[@CR110], [@CR111]\], and possibly *Galago senegalensis* could be infected and contribute to YFV transmission \[[@CR7]\]. Serological and clinical findings related to YFV infection are described in many Neotropical NHP \[[@CR112]--[@CR114]\]. All Neotropical NHP genera are considered susceptible to YFV infection with differing degrees of sensitivity \[[@CR115], [@CR116]\].

Early reports in Brazil showed antibodies against YFV in specimens of *Cebus, Callithrix,* and *Leontopithecus*, in Mato Grosso, Bahia, and Minas Gerais states \[[@CR117]--[@CR119]\]. An extensive immunological survey detected humoral immunity against YFV in *Alouatta*, *Ateles*, *Aotus*, *Callicebus*, *Callithrix*, *Cebus*, *Brachyteles*, *Leontopithecus*, *Pithecia*, and *Saimiri* in Brazil \[[@CR120]\]. A recent study \[[@CR121]\], reported the decline (10 to 26%) of two muriqui populations (*Brachyteles hypoxanthus*), from October 2016 to April 2017, in areas with YF outbreaks \[[@CR55]\], and likely YF was the cause of deaths \[[@CR121]\].

*Alouatta* is described as the most susceptible genus to YFV infection, developing clinical illness and fatal disease \[[@CR114], [@CR122], [@CR123]\], even when infected with low virus inoculum \[[@CR2]\]. However, YFV antibodies have been detected in some specimens of *Alouatta*, showing that some animals survive \[[@CR2], [@CR120], [@CR124], [@CR125]\]. In South America, it is common to hear howling monkeys (*Alouatta* spp.) in the forests, a territorial habit, and their sudden silence is considered a signal for the circulation of YFV \[[@CR33], [@CR89]\]. High numbers of NHP deaths, especially of *Alouatta* spp., have been associated with YF outbreaks in Argentina \[[@CR115], [@CR126]\], Costa Rica \[[@CR127]\], Panama \[[@CR128]\], Venezuela \[[@CR129], [@CR130]\], and Brazil \[[@CR9], [@CR20], [@CR131], [@CR132]\].

Specimens of *Callithrix* are also involved in the sylvatic cycle of YFV in Brazil. Experimental studies demonstrated the susceptibility of *Callithrix albicolis*, *Callithrix penicillata,* and hybrids marmosets to YFV \[[@CR113]\]. Wild specimens of *C. penicillata* presenting histopathological findings suggestive of YFV infection, and marmosets showing anti-YFV antibodies have been reported in many parts of Brazil \[[@CR120], [@CR133]\]. In general, species within the genera *Saimiri*, *Saguinus*, *Aotus*, *Ateles*, *Cebus,* and *Sapajus* have been considered less susceptible to YFV, although *Saimiri, Saguinus* and *Sapajus* specimens may develop the disease, with fatal outcomes \[[@CR9], [@CR20], [@CR89], [@CR114], [@CR134], [@CR135]\].

Since the beginning of the most recent YF outbreak in Brazil (2016--2018), several epizootics have been reported by the MOH and other studies, affecting mostly marmosets and howler monkeys \[[@CR20]--[@CR22], [@CR33], [@CR53], [@CR54], [@CR136], [@CR137]\]. YFV-infected specimens of *Sapajus libidinosus, Alouatta caraya,* and *Alouatta clamitans* have been described (2015--2017) in Goiás and Espírito Santo states \[[@CR53]\]. From 2017 on, genomic and epidemiological studies described YFV infection in NHP in the Southeast region of Brazil. YFV-infected specimens of *Alouatta* spp., *Alouatta clamitans, Callithrix* spp., *Callithrix jacchus, Callithrix penicillata*, *Callicebus* spp., and *Callicebus personatus* were observed in Minas Gerais, Espírito Santo, and Rio de Janeiro states \[[@CR21], [@CR22], [@CR54], [@CR57], [@CR136]--[@CR138]\]. During an investigation of YF epizootics in São Paulo from 2016 to 2017, Cunha and colleagues (2019) confirmed the infection in specimens of *Alouatta, Callithrix,* and *Sapajus*. Based on molecular and immunohistochemistry analyses, the authors suggested that some species of *Callithrix* may have different sensitivity to YFV when compared to *Alouatta* spp. and *Sapajus* spp. \[[@CR20]\].

Although all Neotropical NHP have been considered sensitive to YFV, most of the records and studies are related to *Alouatta* and *Callithrix*. From 2221 NHP deaths, caused by YF, from 1996 until June 2016, in Brazil, the most affected NHP were *Alouatta* sp. (85.0%) followed by *Callithrix* sp. (8.3%), *Sapajus* sp. (0.8%), *Cebus* sp. (0.22%), and *Saimiri* sp. (0.05%). From July 2016 until April 2019, at least 3569 NHP deaths were caused by YF. From these total, most of the identified specimens were *Alouatta* sp. (31.7%) and *Callithrix* sp. (17.1%), followed by *Sapajus* sp. (1.1%) and *Cebus* sp. (1.0%). For the first time, SINAN registered cases of YF in *Callicebus* sp. (0.45%), *Aotus* sp. (0.03%), and *Ateles* sp. (0.03%). Also, the first case of YF was registered in *Leontopithecus rosalia* (golden lion tamarin), an endangered species native of Atlantic Forest (data received from SINAN, June 2019).

Some studies described NHP genera with different degrees of sensitivity to YFV, based on natural infection or few experimental assays. However, the susceptibility of NHP to YF is sometimes estimated using data of animals which died or survived after natural infection. It is also important to note that NHP species have a different distribution throughout Brazil, and their genetic background could influence their susceptibility to YFV. One could expect that NHP from the Amazon Basin, a YF endemic region, could be more resistant to YFV compared to NHP from YFV-free areas. Besides other ecological factors unique to each NHP genus/species, as geographic distribution and behavioral patterns could favor infection.

Pathogenesis of yellow fever in non-human primates {#Sec10}
--------------------------------------------------

Most of the knowledge about the pathogenesis of YF in humans and NHP results from experimentally infected rhesus monkeys (*Macaca mulatta*), *Alouatta* spp., and *Saimiri* spp. \[[@CR114], [@CR139]\]. The first successful infection of a rhesus monkey with YFV was demonstrated in 1928, by Stokes and colleagues (1928). The authors described the main pathological changes related to acidophilic necrosis of the liver parenchyma affecting predominantly the mid-zonal region of the lobule \[[@CR140]\]. Similar findings were later reported in rhesus monkey three days post-inoculation with a high infectious dose (4565--400,000 times of the 50% lethal dose in a mice model). The progress of the disease was marked by an increase in necrotic liver cells, accompanied by an increase in animal temperature. Necropsies demonstrated infiltration of the portal tract and hepatic veins of the liver with inflammatory cells \[[@CR141]\].

In general, NHP exhibit the viscerotropic disease, and YFV can be found in the liver, kidneys, bone marrow, spleen, and lymph nodes \[[@CR142]\]. In rhesus monkeys, the viremia peaks from three to seven days post-infection (with estimated viral titers of 25 TCID~50~ to 5 × 10^4^ TCID~50~), coinciding with the observation of severe disease \[[@CR142]\]. The infection and lesion of hepatocytes have been described as a relatively late event. Eosinophilic degeneration of hepatocytes presenting condensed nuclear chromatin (Councilman bodies), precedes (24-48 h) death in experimentally infected monkeys \[[@CR1], [@CR143]\]. Clinical observations of experimentally infected rhesus monkeys showed necrosis of germinal centers of the spleen, lymph nodes, tonsils, Peyer's patches, and renal failure. Hypoxia, hypotension, and circulatory shock and multi-organ failure are also observed. A systemic inflammatory syndrome (cytokine storm) might contribute to the lethality of YF, but further studies are needed to better understand the role of immunopathological mechanisms during YF \[[@CR1], [@CR13], [@CR143]\]. YFV-infected NHP may present fever, jaundice, dehydration, anorexia, oral and intestinal bleeding, liver injury with hemorrhagic and necrosis foci, and kidney failure \[[@CR33], [@CR137], [@CR142]\].

There are few descriptions of YF histopathological lesions in YFV-naturally infected NHP, especially regarding Neotropical NHP. Leal and colleagues (2016) described liver necrosis in the midzone associated with apoptosis of hepatocytes as the most frequently histopathologic change in naturally infected howler monkeys (*Alouatta* spp). They also observed steatosis, liver hemorrhage, inflammatory mononuclear cell infiltration of the liver, renal acute tubular necrosis, and interstitial nephritis \[[@CR139]\].

Recent YF outbreaks in Brazil opened an opportunity to study naturally infected NHP. Cunha and colleagues (2019) performed immunohistochemistry analyses and observed brown granular cytoplasmic hepatocytes in YFV-positive specimens of *Alouatta* spp. (*n* = 22), *Sapajus* spp. (*n* = 7), but not in five specimens of YFV-positive *Callithrix* \[[@CR20]\]. Two carcasses of female *Callicebus personatus* displayed petechiae in the gastric mucosa, blood clots in the stomach, hemorrhagic and friable spleen, macroscopic changes with yellow areas in the hepatic parenchyma, plus edema in lungs and eyelid, and hyperemia of the eyelid. YFV RNA was detected in the lungs, liver, kidneys, bladder, stomach, and intestine, suggesting that the pathological picture was probably caused by YFV \[[@CR137]\]. Fernandes and colleagues (2017) performed histologic analyses of NHP carcasses (two specimens of *Alouatta* sp and 22 non-identified specimens). They observed massive liver necrosis with Councilman bodies, splenic lymphoid depletion, follicular necrosis, acute renal tubular necrosis, and multisystemic hemorrhage \[[@CR138]\]. One animal from this study presented atypical signs, such as massive steatosis with rare midzonal to random single-cell necrosis and multifocal micro abscesses in the liver, probably associated with an acute intestinal bacterial infection or septicemia. The same animal presented endothelial necrosis and hepatic regeneration signs, as suggested by oval cell hyperplasia \[[@CR138]\]. During the last YF outbreak in Brazil, natural infection of Neotropical NHP resembled experimental infection, but new findings were reported. The comprehensive understanding of YF pathogenesis in Neotropical NHP could bear further studies using alternative animal models, bringing light in important aspects of YF pathogenesis and treatment.

Conclusions {#Sec12}
===========

The changes in the epidemiological pattern of sylvatic YF since the 2000s and unprecedented magnitude of the latest YF outbreak in Brazil are an alert. A new YFV lineage was associated with the 2016--2019 outbreaks. However, whether the mutations observed in this new lineage contribute to viral fitness in vectors or hosts, and possibly to the dynamics of YF is still a matter of investigation. Genomic surveillance and evolutionary studies demonstrated the sustained circulation of YFV before December 2016 until 2019, reaching extensive YF-free areas with a significant number of naïve hosts (human and NHP) and competent vectors.

Although YF is an old disease, much is still unknown about the pathogenesis, clinical aspects of the disease, and patient management. During recent outbreaks in Brazil, the study of a high number of YF patients, who were admitted at high-quality hospitals, brought an opportunity to elucidate some clinical features of the disease, but many gaps are still open, and further studies are needed.

The recent YF outbreaks allowed the investigation of a variety of NHP outside the Amazon Basin. Following the pattern previously observed, most YFV-infected specimens belonged to *Alouatta* spp. and *Callithrix* spp., and for the first time YF was described in *Leontopithecus rosalia.* NHP are amplifier hosts for YFV but are not viral reservoirs since they die or develop cellular and humoral immunity against the virus. However, studies to better understand the duration of protective immunity against YFV in NHP are required.

Further investigation of viremia in Neotropical NHP could contribute to the assessment of sensitivity to YFV and the potential for vector infection. This information is critical for YF surveillance, identification of YF risk-areas, and the establishment of YF control measures and future strategies for NHP conservation. Despite the imminent risk for YF re-urbanization, given YFV-infected NHP inside urban metropolitan areas of Brazil, no human case was epidemiologically linked to the YF urban transmission cycle. Further studies to understand the role of NHP in YFV circulation in different environments are needed, as well as a greater understanding of the impact of YF in NHP populations.

ALT

:   Alanine aminotransferase

AST

:   Aspartate aminotransferase

ICU

:   Intensive care unit

LACEN

:   Reference Laboratories/Brazilian Ministry of Health

MAC-ELISA

:   Immunoglobulin M antibody caption -- Enzyme-linked immunosorbent assay

MOH

:   Brazilian Ministry of Health

NHP

:   Non-human primate

NS

:   Non-structural protein

RT-qPCR

:   Reverse transcription real-time Polymerase chain reaction

SINAN

:   Information System on Diseases of Compulsory Declaration/Brazilian Ministry of Health

TCID~50~

:   Median tissue culture infectious dose

YF

:   Yellow fever

YFV

:   Yellow fever virus

**Publisher's Note**

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Natalia Ingrid Oliveira Silva, Lívia Sacchetto and Izabela Maurício de Rezende contributed equally to this work.

BPD, NIOS, LS, and IMR drafted the work. GST, ADL, and BdT critically revised the manuscript and contributed with intellectual content. All authors approved the final version of the manuscript.

This study was developed in the context of projects supported by different agencies. BPD acknowledges Fundação de Amparo à Pesquisa do Estado de Minas Gerais (FAPEMIG) (APQ-01574-17), GST acknowledges Decit/SCTIE/MoH, BPD and GST acknowledge Secretaria de Estado de Saúde de Minas Gerais (SES-MG)/Secretaria de Estado de Planejamento de Minas Gerais (SEPLAG-MG)/Fundação Oswaldo Cruz (FIOCRUZ)/FAPEMIG (grant Yellow fever) and National Council for Scientific and Technological Development (research fellowships). BdT acknowledges the RESERVOIRS program supported by European (ERDF/FEDER) funds and assistance from Collectivité Territoriale de la Guyane and Direction Régionale pour la Recherche et la Technologie, and the Laboratoire d'Excellence CEBA "Investissement d'Avenir" and managed by the Agence Nationale de la Recherche (CEBA, Ref. ANR-10-LABEX-25-01). LS and IMR acknowledge Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)/BRAZIL (grant 0001- graduate scholarship) and NIOS acknowledge CNPq- (grant graduate scholarship). The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.

The data that support the findings of this study are available from SINAN, but restrictions apply to the availability of these data, which were used under license for the current study, and so are not publicly available. Data are, however, available from the authors upon reasonable request and with permission of the Serviço de Informação ao Cidadão and SINAN/Brazilian Ministry of Health.

Not applicable.

Not applicable.

The authors declare that they have no competing interests.
